Literature DB >> 30930129

Presynaptic control of [3H]-glutamate release by dopamine receptor subtypes in the rat substantia nigra. Central role of D1 and D3 receptors.

Laura Jesús Briones-Lizardi1, Hernán Cortés2, José Arturo Avalos-Fuentes1, Francisco Javier Paz-Bermúdez1, Jorge Aceves1, David Erlij3, Benjamín Florán4.   

Abstract

Substantia nigra pars reticulata is the output station in basal ganglia; its GABAergic neurons control the activity of thalamo-cortical premotor nuclei, thus controlling motor behavior. D1-like and D2-like presynaptic dopamine receptors on subthalamo-nigral afferents by modulation of glutamate release change the firing rate of nigral neurons; however, their relative contribution to the control of glutamate release and their pharmacological properties have not been studied. This is important since the prevalence of the inhibition or stimulation of release determines the firing rate of nigral neurons, therefore motor activity. Here we used depolarization induced [3H]-glutamate release in slices of rat substantia nigra from reserpinized and non-reserpinized rats to explore the relative contribution of the D1-like and D2-like receptor subtypes to the control of glutamate release. We found a significant control of release by D1-like and D3R, and a modest effect of D2R. D4R exerted no effect. Dopamine showed more potency for D3R than for D1-like receptors; however, these latter enhanced release to a greater degree, as shown by the Emax. We also co-activated these to test their interaction; an antagonist interaction of D1-like with D2 and D3R, and an additive between D2 and D3R were found. Pharmacological receptor antagonist effects in release from reserpinized vs. non-reserpinized slices were similar, suggesting that endogenous dopamine stimulates receptors in the same way. These findings suggest differences in the control of glutamate release by different dopamine receptors in the substantia nigra, which could contribute to explaining the effect of dopamine and its agonists on motor behavior.
Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  D1-like receptors; D3 receptors; substantia nigra; subthalamo-nigral pathway

Mesh:

Substances:

Year:  2019        PMID: 30930129     DOI: 10.1016/j.neuroscience.2019.03.051

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Dopaminergic and nitric oxide systems interact to regulate the electrical activity of neurons in the medial septal nucleus in rats.

Authors:  Shahram Zarrabian; Shole Jamali; Soheila Fazli-Tabaei; Abbas Haghparast
Journal:  Exp Brain Res       Date:  2022-08-17       Impact factor: 2.064

2.  Involvement of the dopaminergic system in the reward-related behavior of pregabalin.

Authors:  Yusuf S Althobaiti; Farooq M Almutairi; Fahad S Alshehri; Ebtehal Altowairqi; Aliyah M Marghalani; Amal A Alghorabi; Walaa F Alsanie; Ahmed Gaber; Hashem O Alsaab; Atiah H Almalki; Alqassem Y Hakami; Turki Alkhalifa; Ahmad D Almalki; Ana M G Hardy; Zahoor A Shah
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

3.  Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects.

Authors:  Sacnité Albarrán-Bravo; José Arturo Ávalos-Fuentes; Hernán Cortés; Marina Rodriguez-Sánchez; Norberto Leyva-García; Claudia Rangel-Barajas; David Erlij; Benjamín Florán
Journal:  Biomolecules       Date:  2019-09-01

Review 4.  Epigenetic mechanisms involved in methamphetamine addiction.

Authors:  Hang Wang; Xianghuan Dong; Maher Un Nisa Awan; Jie Bai
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

5.  Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction among Glutamate, Dopamine, and GABA.

Authors:  Marina Rodríguez-Sánchez; Rodrigo Erick Escartín-Pérez; Gerardo Leyva-Gómez; José Arturo Avalos-Fuentes; Francisco Javier Paz-Bermúdez; Santiago Iván Loya-López; Jorge Aceves; David Erlij; Hernán Cortés; Benjamín Florán
Journal:  Biomolecules       Date:  2019-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.